Stay updated on Safety of WVE-210201 in Duchenne Muscular Dystrophy Clinical Trial
Sign up to get notified when there's something new on the Safety of WVE-210201 in Duchenne Muscular Dystrophy Clinical Trial page.

Latest updates to the Safety of WVE-210201 in Duchenne Muscular Dystrophy Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 banner added; notices for a lapse in government funding and the previous Revision: v3.4.1 entry were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a global government-funding notice and updated the site revision to v3.4.1 (replacing v3.4.0).SummaryDifference0.4%

- Check28 days agoChange DetectedGlossary visibility was added; capitalization tweaks were applied to 'Last Update Submitted that Met QC Criteria' and to 'No FEAR Act Data', and the footer now shows 'Revision: v3.4.0' (replacing v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4. There are no substantive changes to the study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedNew study locations added: Georgia (USA) and Ontario (Canada). The page revision was updated to v3.3.3.SummaryDifference0.3%

- Check92 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Safety of WVE-210201 in Duchenne Muscular Dystrophy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of WVE-210201 in Duchenne Muscular Dystrophy Clinical Trial page.